Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

bacterial infections

- PMLiVE

FDA approves Basilea’s intravenous antibiotic Zevtera for three indications

The regulator’s decision provides an additional treatment option for a number of serious bacterial infections

Can Cinderella save us?

Basilea’s novel antibiotic reaches UK market

Zevtera can be used against a range of infections including MRSA

- PMLiVE

FDA approves antibacterial skin drug Orbactiv

US regulator authorises Medicines Company's treatment for ABSSSI

- PMLiVE

Cell wall inhibitors for bacterial infections

There are limited pipeline prospects to address this significant health issue

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links